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Evaluating implementation of methicillin-
resistant Staphylococcus aureus (MRSA)
prevention guidelines in spinal cord injury
centers using the PARIHS framework: a mixed
methods study
Salva N. Balbale1,2,3†, Jennifer N. Hill1,2†, Marylou Guihan1,2,4†, Timothy P. Hogan5,6,7†, Kenzie A. Cameron8,9†,
Barry Goldstein10,11† and Charlesnika T. Evans1,2,3,9*
Abstract
Background: To prevent methicillin-resistant Staphylococcus aureus (MRSA) in Spinal Cord Injury and Disorder (SCI/D)
Centers, the “Guidelines for Implementation of MRSA Prevention Initiative in the Spinal Cord Injury Centers” were released
in July 2008 in the Veterans Affairs (VA) Health Care System. The purpose of this study was to use the Promoting Action
on Research Implementation in Health Systems (PARiHS) framework to evaluate the experiences of implementation of
SCI/D MRSA prevention guidelines in VA SCI/D Centers approximately 2–3 years after the guidelines were released.
Methods: Mixed methods were used across two phases in this study. The first phase included an anonymous, web-based
cross-sectional survey administered to providers at all 24 VA SCI/D Centers. The second phase included semi-structured
telephone interviews with providers at 9 SCI/D Centers. The PARiHS framework was used as the foundation of both the
survey questions and semi-structured interview guide.
Results: The survey was completed by 295 SCI/D providers (43.8 % response rate) from 22 of the 24 SCI/D Centers
(91.7 % participation rate). Respondents included nurses (57.3 %), therapists (24.4 %), physicians (11.1 %), physician
assistants (3.4 %), and other health care professionals (3.8 %). Approximately 36 % of the SCI/D providers surveyed had
not seen, did not remember seeing, or had never heard of the MRSA SCI/D guidelines, whereas 42.3 % of providers
reported that the MRSA SCI/D guidelines were fully implemented in their SCI/D Center. Data revealed numerous barriers
and facilitators to guideline implementation. Facilitators included enhanced leadership support and provider education,
focused guideline dissemination to reach SCI/D providers, and strong perceived evidence supporting the guidelines.
Barriers included lack of awareness of the guidelines among physical therapists and physician assistants and challenges in
cohorting/isolating MRSA-positive patients and following contact precautions.
Conclusions: Successful implementation of MRSA infection prevention guidelines in SCI/D settings requires (1) guideline
dissemination that reaches the full range of SCI/D providers working in inpatient, outpatient, and other care settings,
(2) provider education that is frequent and systematic, (3) strong leadership support, and (4) that barriers unique to the
recommendations are addressed. These findings may be used to inform selection of implementation strategies and
optimize infection prevention beyond MRSA as well as in other specialty care populations.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
responsible for over 11,000 deaths and 200,000 hospitali-
zations in the USA every year, in addition to increases in
health care costs and length of stay [1–4]. In 2007, the
Veterans Affairs (VA) Health Care System released the
MRSA Prevention Initiative [5], describing infection
control strategies to prevent the spread of MRSA in VA
medical centers. This initiative used a bundled intervention
strategy and resulted in decreased MRSA transmission and
infection in the VA [6]. Components of the initiative
included (1) active surveillance and screening cultures
(ASCs), (2) use of contact precautions by health care pro-
viders if patients are found to be MRSA positive, (3) hand
hygiene, and (4) cultural transformation through staff and
leadership engagement [5]. The success of this initiative has
been presented elsewhere including declines in MRSA
infection rates in intensive care unit (ICU) and non-ICU
settings [6, 7].
Additional guidance was provided for prevention of
MRSA in VA Spinal Cord Injury and Disorder (SCI/D)
Centers. Patients with chronic and complex health
needs, such as those with SCI/D, are at particularly high
risk for MRSA and other hospital-acquired infections
(HAI) [7–9]. The “Guidelines for Implementation of
MRSA Prevention Initiative in the Spinal Cord Injury
Centers” (herein referred to as SCI/D MRSA prevention
guidelines) were released in July 2008 [10]. These guide-
lines (Additional file 1) addressed specific elements of
SCI/D care, such as the inclusion of wounds and/or pres-
sure ulcers as part of ASCs. The SCI/D MRSA prevention
guidelines also emphasized hand hygiene in patients and
providers before and after urinary catheterization and
bowel care, addressed appropriate cleaning of shared
equipment, and highlighted the need for contact precau-
tions and environmental cleaning. The initiative was based
on evidence from the Centers for Disease Control around
management of multidrug-resistant organisms in health
care settings [11]. Although research evidence clearly
supports the components of the guidelines related to hand
hygiene, contact precautions, and the presence of leader-
ship and culture change [12, 13], the strength of evidence
underlying the universal screening and isolation strategy is
less clear [14]. Similar to the ICU and non-ICU settings,
significant decreases in MRSA infection rates have been
seen in VA SCI/D Centers [7].
Given the success of the MRSA Prevention Initiative
in VA overall and in SCI/D Centers [6, 7], identifying
barriers and facilitators that impacted early guideline
implementation in SCI/D Centers is a critical step to
enhance implementation of future prevention initiatives
that are rolled out. Successful infection prevention depends
on effective implementation of evidence-based guide-
lines [15, 16]. However, translating infection prevention
guidelines into practice in SCI/D Centers can be espe-
cially challenging due to several characteristics unique
to patients with SCI/D and their needs and experiences
[7, 9]. Specifically, patients with SCI/D are more suscep-
tible to MRSA colonization and infection due to frequent
and prolonged hospitalization [9, 17], frequent contact
with body fluids (e.g., during bowel programs and bladder
catheterization), high prevalence of pressure ulcers
[18, 19], and extensive antibiotic use due to infections
such as urinary tract infections and pneumonia [9, 20].
Controlling the spread of MRSA in hospital settings
where individuals with SCI/D are present is further
complicated by the use of common areas for rehabili-
tation and exercise, shared equipment, and difficulties
in performing hand hygiene among patients with impaired
hand function secondary to tetraplegia.
Previous studies on guideline implementation have
demonstrated that without systematic and tailored imple-
mentation strategies, little impact is observed on routine
clinical practice [21–23]. Prior implementation studies
also have demonstrated the importance of using theory-
based approaches or conceptual frameworks, such as the
Promoting Action on Research Implementation in Health
Systems (PARiHS), to comprehensively evaluate imple-
mentation [16, 24–26]. The purpose of this study was to
use the PARiHS framework to evaluate implementation of
the SCI/D MRSA prevention guidelines in VA SCI/D
Centers approximately 2–3 years after the guidelines were
released.
Methods
Study design and participants
Quantitative and qualitative approaches were used across
two phases in this mixed methods study. We focused on
providers’ experiences with early implementation of the
SCI/D MRSA prevention guidelines and recommended
practices, approximately 2–3 years following the release of
the guidelines. Additionally, we assessed provider percep-
tions and familiarity with the guidelines, factors influen-
cing early implementation, and attitudes on prevention
practices and perceived strength of evidence around
MRSA severity and prevention.
This study was focused on the 24 regional SCI/D
Centers that were part of the VA SCI/D System of Care
at the time of the study. The first phase of the study
included an anonymous, web-based cross-sectional sur-
vey administered in August 2010 to providers at all 24
VA SCI/D Centers. The sampling frame was identified
through VA electronic mailing lists (LISTSERVs) of
providers working in SCI/D Centers and a contact list
of MRSA Prevention Coordinators (MPCs) across the
country. Local MPCs maintain responsibility for ensur-
ing implementation of the MRSA Initiative at each VA
inpatient facility. Survey data were collected as part of
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a broader effort to characterize MRSA prevention
practices in SCI/D Centers following guideline release.
Although the initial sample of providers was composed of
MPCs at each Center’s facility, as well as the SCI/D Center
Chief, SCI/D Center physicians, nurses, therapists, and
other allied health providers, we only describe survey data
from the SCI/D Center physicians, nurses, therapists, and
allied health providers. MPC survey data were omitted
from our analysis as these data did not focus on percep-
tions of guideline implementation.
The second phase of the study included semi-structured
telephone interviews with providers at nine of the SCI/D
Centers, which occurred December 2010–March 2011.
The research team selected interview questions about
current practices that were critical to guideline implemen-
tation [27]. Participants were recruited through the SCI/D
Chief, Infection Control Coordinator, MPC, or other
designated leaders at each of the nine VA facilities.
Background on the objectives of the study was provided,
and permission to interview providers requested. A
recruitment letter about the study also was distributed to
potential participants.
This study was approved by the Institutional Review
Board at the Hines VA Hospital. Further details on the
study design and data collection efforts are published
elsewhere [27].
Conceptual framework
The PARiHS framework was used as the foundation of
both the survey questions and semi-structured interview
guide (Additional file 2: Appendix A). The PARiHS
framework proposes that successful implementation of
evidence into practice is a function of three broad inter-
active elements: evidence, context, and facilitation [28–30].
Given the lack of knowledge around infection prevention
guideline implementation in SCI/D, we focused on building
our understanding around contextual factors that affected
early implementation of the SCI/D MRSA prevention
guidelines at each VA SCI/D Center, with a secondary
focus on evidence and facilitation factors influencing
early implementation.
Survey procedures and instrument
Catapult Systems Corporation’s InquisiteWeb Survey
System 7.0 was used to administer the anonymous sur-
vey. Respondents were provided with an electronic link
through an email invitation generated by the system; the
survey was available for 3 weeks. Two reminder emails
were sent during this period to those who had not com-
pleted the survey.
The survey included questions designed to explore
early implementation of the SCI/D MRSA prevention
guidelines as well as demographic questions, including
type of provider, age, number of years in training, VA
facility, and supervisory status. Questions explored attri-
butes known to influence guideline adoption [29–31],
including (1) providers’ perceived strength and extent of
evidence underlying the guidelines, (2) the quality of the
organizational context for guideline implementation, and
(3) facilitation efforts to implement the SCI/D MRSA
prevention guidelines.
Semi-structured interview procedures
Qualitative data were collected to examine the factors
shaping provider survey responses and guideline imple-
mentation. Survey data were used to select the study
sites for interview [27]. The research team selected survey
questions to gather information about frequency of pro-
vider engagement in practices from the guidelines that are
critical for MRSA prevention. These practices include
conducting active surveillance, placing MRSA-positive
patients on contact precautions, and educating patients
and caregivers on MRSA prevention. The percentage of
survey respondents from each SCI/D Center who reported
“usually/always” performing these prevention practices
was used to create a summary score for their respective
SCI/D Center. We used these summary scores to organize
facilities into low, medium, and high scores. A sample of
2–4 SCI/D Centers was selected from each of these
groups for a total of nine study sites. To ensure adequate
representation from leadership within the SCI/D Center
and infection control, interviewees included at least one
designated leader in the SCI/D Center for the MRSA
program and the MPC or another infection control repre-
sentative. We recruited up to four participants at each
facility. Interview participants were unaware of the selec-
tion process.
Four authors (JNH, TPH, KAC, and MG) trained in
qualitative data collection conducted the interviews.
Informants were first asked to respond to a short set of
background questions regarding demographics, profes-
sional training, and work experience. A one-on-one,
semi-structured, audio-recorded interview followed, last-
ing from 30 to 60 min. Interview questions were related
to perceptions of early efforts to implement the SCI/D
MRSA prevention guidelines and the range of facilitating
or impeding factors influencing their implementation.
Analysis
All survey questions were described using univariate
statistics (frequencies, percentages, and means) and
chi-square statistics. Analysis of perceived level of im-
plementation and guideline awareness across provider
types involved multiple comparisons; to minimize the
possibility of type I error, we applied a Bonferroni-
corrected alpha level as the criteria of statistical signifi-
cance for these tests. We used an alpha level of 0.017
for comparisons of perceived level of implementation
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across provider groups and an alpha level of 0.008 to
compare guidelines awareness across provider groups.
All analyses were conducted using SAS software version
9.2 (SAS Institute Inc, Cary, NC, USA).
Audio-recorded interviews were transcribed verbatim
and compared with the original recordings to ensure
transcription accuracy. All personal identifiers were
removed, and the transcripts were distributed to the
coders. Transcripts were analyzed using a constant com-
parative technique to organize the content into categories,
identifying both common and unique themes across inter-
views [32, 33]. A preliminary coding scheme was devel-
oped, and interviews were independently coded by four
research study members (JNH, TPH, KAC, and MG),
where each interview was independently coded by at least
two study members. Discrepancies in coding were further
refined based on discussions between the coders. In line
with the PARiHS model, we explored the different ele-
ments of context, evidence, and facilitation associated
with guideline implementation across the nine sites as
well as provider perceptions related to implementation
of the SCI/D MRSA prevention guidelines.
Results
Quantitative survey
The survey was completed by 295 SCI/D providers
(43.8 % response rate) from 22 of the 24 SCI/D Centers
(91.7 % participation rate). Respondents were excluded
in cases of (1) incomplete surveys, (2) undeliverable
responses due to termination of VA employment, and
(3) providers who did not treat patients with SCI/D or
were not involved in direct patient care. Thus, our final
eligible sample size included 234 potential respondents
(34.8 % response rate). Respondents included nurses
(57.3 %), therapists (24.4 %), physicians (11.1 %), physician
assistants (3.4 %), and other health care professionals
(3.8 %). The percentage of each provider type who
responded was 40.1 % of nurses, 16.8 % of physicians,
42.1 % of physician assistants, 33.5 % of therapists, and
4.7 % of other health care professionals. Respondents
cared for SCI/D patients in inpatient, outpatient, long-
term care, and home care settings. Table 1 includes demo-
graphic characteristics of the responding SCI/D Center
providers. Although responses to the survey were anonym-
ous, we compared the original sampling frame to those that
responded by provider type [27]. When comparing survey
respondents to the original sampling framework, the distri-
bution of respondents was similar for nurses, therapists,
and physician assistants. However, physicians were less
likely to participate in the survey (11 % of respondents
compared to 23 % of the sampling frame).
Overall, 42.3 % of providers reported that the SCI/D
MRSA prevention guidelines were fully implemented in
their SCI/D Center, followed by 47.0 % that indicated
mostly, and 10.7 % that they were partially implemented.
Across the 22 sites, perceptions of full implementation
of the guidelines ranged from 0–100 %. Nurses were sig-
nificantly more likely to report full implementation of
the guidelines compared to other positions at the
Bonferroni-corrected alpha level of p < 0.017 but were
similar in comparison with physicians (Table 1); no sig-
nificant difference was found between physicians and
other positions (p = 0.258). Perceived level of implemen-
tation did not differ significantly across levels of nurse
education.
Table 2 reports respondents’ familiarity with the SCI/D
MRSA prevention guidelines, perceptions around imple-
mentation of the guidelines, and specific prevention
practices in their SCI/D Center, by perception of full imple-
mentation. Compared to those who did not, staff members
who perceived the guidelines to be fully implemented were
more likely to endorse other factors that contribute to
guideline implementation such as being aware of the guide-
lines, having resources to implement the guidelines includ-
ing provider support, training and funding, and perceiving
a beneficial impact on prevention of MRSA transmission
and infection in patients with SCI/D. Those who reported
full implementation were also more likely to report hygiene
practices such as bathing patients with SCI/D every day
and encouraging hand hygiene in visitors/family members
and patients. Barriers to cohorting patients or patient hand
hygiene were not associated with perception of implemen-
tation; however, some differences in barriers were noted for
providers in changing gowns and gloves in-between pa-
tients. Multi-bed rooms, expense of gowns and glove sup-
plies, and providers not following guidelines were more
frequently reported in those who felt that the guidelines
were not fully implemented.
Perceived strength of research evidence among providers
was also assessed (Table 3). Most providers perceived evi-
dence underlying the SCI/D MRSA prevention guidelines
to be strong. Perceived strength of evidence was generally
stronger in the fully implemented group for several key
MRSA prevention practices, including active surveillance
measures at admission, hand hygiene, and gowning and
glowing before entering a MRSA patient’s room.
Table 4 describes awareness of the SCI/D MRSA preven-
tion guidelines by provider characteristics. Of the SCI/D
providers surveyed, 36.8 % had not seen, did not remember
seeing, or had never heard of the SCI/D MRSA prevention
guidelines. A smaller proportion of physical therapists and
assistants reported being aware of the guidelines compared
to nurses. We did not find a statistically significant differ-
ence in guideline awareness across provider types. Guide-
line awareness was strongest among providers in the initial
years of their experience in working with SCI/D patients.
There was no difference in awareness across years of
experience when stratified by provider type.
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Table 1 Provider demographic characteristics
SCI/D providers n = 234
Frequency (%)
Type of SCI/D unit setting worked
in most of the time
Long-term care 23 (9.8)
Inpatient unit 177 (75.7)
Outpatient clinic 27 (11.5)
Home care 7 (3.0)
Gender
Male 56 (24)
Female 178 (76)
Provider type
Nurse 134 (57.3)
Therapist 57 (24.4)
Physician 26 (11.1)
Other 9 (3.8)
Physician assistant 8 (3.4)
Type of nursea n = 81
Bachelor of Science Registered
Nurse (BSRN)
36 (44.4)
Licensed Practical Nurse (LPN) 21 (25.9)
Master of Science—Nursing (MSN) 7 (8.7)
Nurse Practitioner (NP) 6 (7.4)
Otherb 11 (13.6)
Type of therapist n = 57
Occupational therapist 21 (36.8)
Physical therapist 18 (31.6)
Therapeutic recreation therapist 11 (19.3)
Otherc 7 (12.3)
Percentage of time spent on direct
patient carea
n = 226
Average time spent 64.7 %
Range: 0–100 %
Average number of years working
with patients with SCI/D*
10.9 years
Range: 1–40 years
SCI/D provider characteristics by perceived
degree of implementation
n = 228
Frequency (%)
Fully implemented Not fully implemented p value (chi-square)
Position at the VA 0.035
Nurse 63 (65.63) 66 (50) Ref
Physician 11 (11.46) 15 (11.36) 0.544
All others 22 (22.92) 51 (38.64) 0.010
Type of SCI/D unit setting worked
in primarily
0.506
Home care 1 (1.04) 4 (3.03)
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Qualitative themes
Thirty interviews were conducted across nine SCI/D
Centers in the second phase of the study. The final
make-up of the interview sample (n = 30) included 16
nurses (8 registered nurses, 7 Bachelor of Science regis-
tered nurses, 1 certified nursing assistant), 9 physicians,
4 physical therapists, and 1 physician assistant. Three of
the nurses were also MPCs. We used the qualitative
interview data to examine the provider perspective and
better understand providers’ survey responses. Prominent
themes emerging from the data included provider aware-
ness of the SCI/D MRSA prevention guidelines, perceived
evidence supporting the guidelines, as well as leadership
support and resources to facilitate implementation of
the guidelines. Themes were grouped according to the
PARiHS constructs (context, evidence, and facilitation)
to explore factors influencing guideline implementation in
VA SCI/D Centers (Additional file 3: Appendix B). Key
survey results were linked with our qualitative findings to
triangulate our data and interpret their relevance to
implementation.
Context
Awareness of the SCI/D MRSA prevention guidelines
varied significantly across the nine sites, where some pro-
viders had greater familiarity and others reported limited
or no exposure to them. Based on survey findings,
approximately 64 % of SCI/D providers surveyed were
aware of the guidelines. Guideline awareness was generally
higher among providers who perceived the guidelines to
be fully implemented, compared to those who felt the
guidelines were not fully implemented. Interview data
revealed possible factors within the receptive context that
may be driving a lack of guideline awareness, including
gaps in the dissemination of the guidelines.
Providers reported varied experiences in learning about
and accessing the SCI/D MRSA prevention guidelines.
Guideline dissemination did not always reach all providers
systematically. Among SCI/D providers interviewed, phys-
ical therapists and physician assistants generally reported
not learning about the guidelines. One physical therapist
who had not read the guidelines reported: “Everything that
I’ve seen is second hand information that I am told through
education…but as far as reading the [SCI/D MRSA preven-
tion guidelines] policy myself, no [I have not].” Another
physical therapist noted a disconnection in awareness of
the guidelines between newer providers and those who had
worked in a VA SCI/D Center longer.
Other providers were very familiar with the guidelines
and were able to access them frequently. One SCI/D
nurse said: “I’m pretty familiar [with the SCI/D MRSA
prevention guidelines]…and I actually have it on my
desktop always.” Others reported that they had some
familiarity with the guidelines but did not have in-depth
knowledge around them and had not reviewed them
recently. An SCI/D nurse reported: “I’m not like the cli-
nicians where I know it by heart or anything like that. I
know the basic process.”
Another key component of the receptive context of
implementation was a sense of receptivity to change
among providers. This often included practices and
strategies initiated by providers to better implement
practices from the SCI/D MRSA prevention guidelines.
One physician noted one example of such an activity to
promote patient hand hygiene: “[Providers] getting hand
sanitizer for patients at the bedside because they know
bed-bound patients do self-care.”
Providers commented on contextual aspects specific to
the culture within their SCI/D Centers and MRSA pre-
vention program. One nurse/MPC described a prevailing
belief within her SCI/D Center to be more lenient with
respect to implementation of the SCI/D MRSA prevention
guidelines, compared to acute care settings where she per-
ceived a greater need for MRSA prevention: “It’s… acute
care where we want [MRSA prevention] to be the most
stringent; and then spinal cord injury is a little more leni-
ent.” In addition, one nurse commented on steps her SCI/
D Center had taken to promote learning and adoption of
contact precautions, as well as to improve patient and
provider safety: “We spearheaded… and developed isola-
tion signage that is consistent…colors, verbiage and every-
thing. That’s how we present isolation. When we teach it,
it’s like ‘this is for your protection and also the protection
of the multiple patients you care for.’”
Table 1 Provider demographic characteristics (Continued)
Inpatient unit 78 (81.25) 97 (73.48)
Long-term care 8 (8.33) 14 (10.61)
Outpatient clinic 9 (9.38) 17 (12.88)
Gender 0.584
Male 75 (78.13) 99 (75)
Female 21 (21.88) 33 (25)
aIndicates missing values
bIncludes clinical educators and certified nursing assistant (CNA)
cIncludes kinesiotherapists and respiratory therapists
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Table 2 Provider survey responses, by perceived degree of implementation
n = 228
Frequency (%)
Fully implemented Not fully implemented p value (chi-square)
Have seen the VA guidelines for MRSA
prevention in SCI/D Centers
76 (79.17) 69 (52.27) <0.0001
Agreea that your SCI/D center/
interdisciplinary team works closely
with the hospital MRSA Prevention
Coordinator (MPC) to prevent MRSA
transmission
72 (75) 85 (64.39) 0.0877
There is a person or a group of people
(aside from the hospital MPC) responsible
for implementation of SCI/D Center MRSA
Program guidelines in your unit
69 (71.88) 75 (56.82) 0.02
Agreea that staff resources provided by the
SCI/D Chief to implement the SCI/D MRSA
Program are adequate
79 (84.04) 75 (61.98) 0.0004
Agreea that training resources provided by
the SCI/D Chief to implement the SCI/D
MRSA Program are adequate
76 (81.72) 76 (63.87) 0.0042
Agreea that funding resources provided by
the SCI/D Chief to implement the SCI/D
MRSA Program are adequate
45 (70.31) 41 (43.16) 0.0008
Agreea that implementation of the SCI/D
Center MRSA Program guidelines has
greatly improved your ability to prevent
MRSA transmission to MRSA-negative
patients in the SCI/D unit
71 (73.96) 65 (49.24) 0.0002
Agreea that implementation of the SCI/D
Center MRSA Program guidelines has
greatly improved your ability to prevent
MRSA infection in all SCI/D patients
65 (67.71) 58 (43.94) 0.0004
Usually or alwaysb indicate in a signed/
dated progress note that communication
with a patient about MRSA screening has
occurred
56 (65.12) 39 (34.82) <0.0001
Frequency of practicing the following in
your SCI/D center
Usually or alwaysb encourage visitors/
family members to
perform hand hygiene before/after all
patient contact
82 (88.17) 86 (68.25) 0.0006
Usually or alwaysb encourage SCI/D
patients to perform
hand hygiene before/after interacting with
other patients
80 (84.21) 79 (61.72) 0.0002
Usually or alwaysb encourage SCI/D
patients with impaired hand function
to ask for assistance to perform hand
hygiene
82 (86.32) 82 (64.57) 0.0003
Usually or alwaysb bathe SCI/D patients
every day
31 (43.66) 29 (28.16) 0.0344
Agreea that health care worker hand
hygiene is an effective way to reduce
MRSA transmission and the development
of MRSA infections in SCI/D patients
94 (97.92) 125 (94.7) 0.2177
Agreea that I feel comfortable reminding
other staff in the SCI/D unit when they
do not clean their hands
74 (77.08) 79 (59.85) 0.0062
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Evaluation, another contextual sub-element, was also
discussed. Specifically, providers reflected on individual-
and system-level feedback received on their performance
if they were effectively implementing prevention practices
and also if there was a need to improve implementation of
specific prevention practices. One nurse commented: “I
do get feedback from [SCI/D leadership]. When [staff] do
really great, we get very good feedback…. If they’re not
doing so great, we get support from leadership saying ‘this
is important,’ ‘please do the swabs,’ ‘make sure you adhere
to contact precautions,’ or ‘continue educating patients on
the importance of hand hygiene.’”
Evidence
In terms of research evidence, providers generally per-
ceived strong evidence for the prevention practices listed
in the SCI/D MRSA prevention guidelines, including
hand hygiene, contact precautions, and active surveillance.
Table 2 Provider survey responses, by perceived degree of implementation (Continued)
Agreea that patient hand hygiene is an
effective way to reduce MRSA transmission
and development of MRSA infections in
SCI/D patients
91 (94.79) 113 (85.61) 0.0257
Agreea that MRSA colonization can be
prevented in SCI/D patients
66 (70.97) 74 (62.71) 0.2076
Agreea that MRSA transmission in
hospitalized SCI/D
patients can be prevented
77 (81.05) 92 (73.6) 0.1945
Barriers to cohorting/isolating
MRSA-positive patients
Availability of beds 63 (65.63) 85 (64.39) 0.8475
Too many MRSA-positive patients 60 (62.5) 72 (54.55) 0.2297
Layout of unit 24 (25) 47 (35.61) 0.0877
Patients refuse or get upset 20 (20.83) 34 (25.76) 0.3879
Visitors/family members refuse or get
upset
21 (21.88) 37 (28.03) 0.292
Too busy 7 (7.29) 9 (6.82) 0.8901
Delayed time to get results 13 (13.54) 18 (13.64) 0.9836
Disrupts work flow of unit 15 (15.63) 26 (19.7) 0.4293
Other 10 (10.42) 24 (18.18) 0.1041
Barriers to patient hand hygiene in your
SCI/D unit
Not enough staff available to assist 19 (19.79) 34 (25.76) 0.2924
Inadequate availability of wheelchair
accessible sink with soap and water
9 (9.38) 22 (16.67) 0.1127
Inadequate availability of touchless
soap or hand sanitizer
16 (16.67) 34 (25.76) 0.1014
Patient unwilling to perform hand
hygiene
52 (54.17) 85 (64.39) 0.1195
Other 21 (21.88) 27 (20.45) 0.7951
Barriers to changing gown and gloves
in-between patients
SCI/D unit layout 9 (9.38) 31 (23.48) 0.0057
Competing demands/too busy 27 (28.13) 38 (28.79) 0.9128
Multi-bed rooms 37 (38.54) 71 (53.79) 0.0228
Expense of supplies 3 (3.13) 17 (12.88) 0.0102
Staff do not follow the SCI/D Center
MRSA Program guidelines
15 (15.63) 37 (28.03) 0.0275
Other 20 (20.83) 33 (25) 0.4621
aAgree = Strongly agree/agree versus neutral/disagree/strongly disagree
bUsually/always = usually/always versus sometimes/rarely/never
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Table 3 Perceived strength of evidence among providers, by perceived degree of implementation
n = 228
Frequency (%)
Fully implemented Not fully implemented p value (chi-square)
Perceived strength of evidence for prevention of MRSA
transmission in SCI/D patients for the following practices
Gloving and gowning before entry into a MRSA-positive
patient’s room
<0.0001
Very strong/strong 86 (89.58) 86 (65.15)
Neutral/weak/very weak/don’t know 10 (10.42) 46 (34.85)
Taking off gloves and gown before leaving a patient’s room. 0.0001
Very strong/strong 88 (91.67) 94 (71.21)
Neutral/weak/very weak/don’t know 8 (8.33) 38 (28.79)
That anyone entering a MRSA-positive patient’s room should
wear gown and gloves
<0.0001
Very strong/strong 80 (83.33) 68 (51.52)
Neutral/weak/very weak/don’t know 16 (16.67) 64 (48.48)
Perceived strength of evidence for handwashing to prevent
the spread of resistant organisms (including MRSA) in SCI/D
Health care workers before and after patient contact 0.012
Very strong/strong 90 (93.75) 109 (82.58)
Neutral/weak/very weak/don’t know 6 (6.25) 23 (17.42)
Visitors/family members before and after patient contact 0.001
Very strong/strong 79 (82.29) 83 (62.88)
Neutral/weak/very weak/don’t know 17 (17.71) 49 (37.12)
SCI/D patients 0.004
Very strong/strong 73 (76.04) 76 (57.58)
Neutral/weak/very weak/don’t know 23 (23.96) 56 (42.42)
SCI/D patients with poor hand function 0.044
Very strong/strong 63 (65.63) 69 (52.27)
Neutral/weak/very weak/don’t know 33 (34.38) 63 (47.73)
Perceived strength of evidence that supports the following
practices in SCI/D units
Active surveillance at admission 0.002
Very strong/strong 79 (82.29) 84 (63.64)
Neutral/weak/very weak/don’t know 17 (17.71) 48 (36.36)
Active surveillance at transfer to another unit <0.0001
Very strong/strong 76 (79.17) 69 (52.27)
Neutral/weak/very weak/don’t know 20 (20.83) 63 (47.73)
Active surveillance at discharge 0.0001
Very strong/strong 76 (79.17) 72 (54.55)
Neutral/weak/very weak/don’t know 20 (20.83) 60 (45.45)
Active surveillance of wounds or pressure ulcers 0.0004
Very strong/strong 73 (76.04) 70 (53.03)
Neutral/weak/very weak/don’t know 23 (23.96) 62 (46.97)
Rescreening during long admissions <0.0001
Very strong/strong 67 (69.79) 57 (43.18)
Neutral/weak/very weak/don’t know 29 (30.21) 75 (56.82)
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Findings from the survey showed that providers who
perceived the guidelines to be fully implemented also
perceived stronger evidence supporting the guidelines,
as compared with providers who did not perceive full
implementation.
Interview data highlighted practices that providers per-
ceived to be particularly important for MRSA prevention in
SCI/D, often corresponding with survey responses. Hand
hygiene was also associated with strong or very strong per-
ceived research evidence in the survey data. One physician
stated: “The most important, in my opinion, is that
[providers] follow the hand washing…that’s the number
one thing we can do to prevent the spread of [MRSA].”
Other areas with strong perceived evidence included con-
tact precautions and active surveillance in SCI/D Centers.
One nurse stated: “[Providers] need to know the precau-
tions, to make sure [patients] are put on contact precau-
tions immediately to prevent the spread of MRSA.” A
nurse stated: “Certainly [active] surveillance is important…
because it gives us the power to get patients on contact
isolation in a timely matter.” One nurse/MPC commented:
“Hand hygiene and isolation is always important….[And]
patients participating in education and performing hand
hygiene. I think that is important in spinal cord [injury].”
Clinical experiences were often viewed by providers as
evidence supporting the SCI/D MRSA prevention guide-
lines. Providers reflected on their own clinical experi-
ences around MRSA prevention, many noting that they
found specific guidelines for contact precautions and
active surveillance to be especially relevant for MRSA
prevention. Based on their experiences, many providers
also believed that MRSA was the most problematic
infection-causing organism in their SCI/D Center. One
physician stated: “It’s just by my clinical experience
[in SCI/D] that I have had more issues with patient
having MRSA…it’s just relative to the other bugs that
I seem to have experience with.”
Interview data also revealed possible contextual factors
in knowledge that may explain weaker perceived evidence
in the “not fully implemented” group. When asked to
comment on the importance of components of the guide-
lines, one nurse stated: “It’s hard for me to comment on
that because I’m just not really sure.” A nurse/MPC com-
mented: “I used to be pretty familiar [with the guidelines]
at least when they were first released…I guess I probably
can’t talk [about] the specifics.” In addition, some providers
reported a lack of information from their own local context.
One physician discussed the lack the data on “success
Table 4 Awareness of SCI/D MRSA prevention guidelines, by provider characteristics
n = 228
Frequency (%)
Awareness of SCI/D MRSA prevention guidelines
Provider characteristic Aware of guidelines Not aware of guidelines p value (chi-square)
All providers 144 (63.2) 84 (36.8)
Gender 0.664
Male 33 (66.1) 21 (38.9)
Female 112 (64.4) 62 (35.6)
Provider type 0.238
Nurse 89 (69.0) 40 (31.0) Ref
Physician 16 (61.5) 10 (38.5) 0.458
Physician assistant/therapist 35 (55.6) 28 (44.4) 0.068
Other 5 (50) 5 (50) 0.216
Experiencea (n = 186) 0.026
0–2 years 23 (85.2) 4 (14.8)
3–5 years 23 (63.9) 13 (36.1)
6–8 years 14 (43.8) 18 (56.3)
9 years or more 57 (62.6) 34 (37.4)
Type of SCI unit 0.009
Inpatient unit 121 (69.1) 54 (30.9) Ref
Outpatient clinic 14 (53.9) 12 (46.1) 0.121
Long-term care 8 (36.4) 14 (63.6) 0.002
Home care 2 (40.0) 3 (60.0) 0.167
aIndicates missing values
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rates” of one particular practice (swabbing of SCI/D
patient wounds) included in the active surveillance com-
ponent of the SCI/D MRSA prevention guidelines: “I don’t
have data on the success rate of…[swabbing wounds], but
the goal is that…all wounds are screened on admission.”
Facilitation
Providers reported that efforts to facilitate implementa-
tion of the SCI/D MRSA prevention guidelines varied
across the sites. These included leadership support, efforts
to provide routine training and education, and to engage
providers in the prevention initiative. Survey findings indi-
cated that providers who perceived the guidelines to be
fully implemented also believed that provider support,
training, and funding resources were generally adequate
to help implement the guidelines. Providers who felt the
guidelines were not fully implemented often found these
resources to be insufficient and, during the interviews,
identified areas of improvement that could better facilitate
implementation.
A key sub-element of facilitation was the role played
by leadership to enable providers and support them in
implementing the SCI/D MRSA prevention guidelines.
Providers discussed several aspects of the facilitation role
played by leadership at their SCI/D Center. One nurse
stated: “[Infection Control and the SCI/D Chief] gave us
a timeline on when these things had to be implemented,
what we would need for each unit…how education was
going to roll out to the staff…they gave us packets to be
circulated. They were available online but you also had
them if you wanted to put them in your hands. And they
were going to do several education sessions about
MRSA to staff. So they started setting that up and we
would make sure all our staff attended to get an under-
standing of what we were doing.”
Other providers discussed leadership efforts that pro-
moted adherence to the guidelines, such as placing hand
hygiene stations and personal protective equipment in
areas that would be most convenient for providers. One
physical therapist commented: “[Leadership] makes sure
that we have lots of contact precaution stuff out by every
room.…That’s a huge help, making sure that they are
stocked all the time so that people aren’t running around
trying to find things….And they encourage people to
comply.”
In addition, the role of internal agents within the SCI/
D Center, such as MPCs and SCI/D leadership, as well
as external agents, including infection control teams and
broader hospital leadership, was a facilitator to support
guideline implementation. One physical therapist com-
mented on one of the roles played by infection control:
“The Infection Control team comes in to make sure we
have all the hand sanitizers readily available throughout
the entire ward, throughout every clinic and room…
They provide a lot more of the contact precaution carts
and signs to alert all the staff that the patient is on con-
tact [precautions] and have the equipment readily avail-
able to kind of increase compliance.” Efforts to monitor
implementation of and compliance with the guidelines
were also a facilitating role. Among the “fully imple-
mented” group, a majority of providers reported that there
was a person or group (aside from a hospital MPC) desig-
nated by leadership at their SCI/D Center to be respon-
sible for implementing the guidelines, often improving
compliance. One physician stated: “We have anonymous
monitors on our ward. They monitor hand washing…they
also monitor gowning and gloving and that’s reported as
well. The leadership here…discuss…various ideas about
how we can manage…maybe like drawing in an imaginary
circle or maybe even a literal circle with tape on the floor
around the bed and if you were to cross that you should
gown.”
Finally, formal training organized and led by SCI Chiefs
and MPCs was also an important facilitator to build
providers’ initial awareness of the guidelines. These train-
ings used a didactic, traditional teaching approach deliv-
ered primarily through in-service sessions and educational
materials tailored for SCI/D providers. While some
providers learned about the SCI/D MRSA prevention
guidelines directly from their MPCs/infection control
or SCI/D Chiefs, others learned about them through
VA education and training events facilitated by leader-
ship. One nurse stated: “I [learned about the guidelines]
from the MRSA Prevention Coordinator since the ini-
tiative started here…I got the initial directive when it
came out.” Another nurse reflected: “Our SCI/D Chief
had a meeting…and mentioned the guidelines. And then
we may go and actually look at them ourselves.”
When providers indicated that leadership was not as ac-
tively involved, improvements suggested included a need
for greater leadership involvement to increase provider
buy-in and receptivity to the guidelines. One nurse/MPC
indicated that “What we would need to make the [SCI/
D MRSA] program more successful is more leadership
support. There need to be consequences for not follow-
ing the MRSA bundles.”
Discussion
Few studies have explored the implementation of infection
prevention guidelines in SCI/D. In this study, we com-
bined the strengths of quantitative and qualitative
methods [34–36] and used the PARiHS framework to
evaluate efforts to implement the SCI/D MRSA preven-
tion guidelines approximately 2–3 years following their
release in VA SCI/D Centers. We focused on SCI/D
provider perceptions, experiences, and insights into fac-
tors influencing implementation of the SCI/D MRSA
prevention guidelines. Through this approach, we better
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understood the context in which SCI/D providers imple-
ment the guidelines and identified several implementation
barriers and facilitators. If generalizable, lessons learned
from this study may be used to optimize the continued
implementation of MRSA infection prevention in SCI/D
Centers, can be applied to enhance implementation strat-
egies for other HAI prevention efforts in SCI/D, such as
C.difficile infection prevention, and, finally, can be used as
a model for evaluating implementation of guidelines in
long-term care or other specialty care settings, such as
polytrauma.
Variation in the implementation of the SCI/D MRSA
prevention guidelines was reported across VA SCI/D
Centers in this study, perhaps due to varying contextual
factors at each site. Based on survey data, nearly 60 % of
SCI/D providers believed that the SCI/D MRSA preven-
tion guidelines were not fully implemented in VA SCI/D
Centers. Several contextual and facilitation-related fac-
tors were explored in the interviews with providers to
understand barriers and facilitators to implementation.
These included variations in provider training, familiar-
ity and awareness of guidelines, as well as organizational
culture at SCI/D Centers, provider clinical experiences,
and local leadership support and roles to facilitate imple-
mentation. Perceived evidence underlying the guidelines,
although strong overall, was weaker among providers who
did not perceive the guidelines to be fully implemented.
Accounting for local contextual differences at SCI/D Cen-
ters will be important in designing future strategies to im-
prove implementation of infection prevention guidelines in
the SCI/D setting.
Challenges in implementing evidence-based guidelines
are a well-documented problem in health care settings
[22]. Prior studies have also highlighted the variability
that exists in the implementation and subsequent suc-
cess of HAI prevention programs [16, 37]. In SCI/D care
delivery, a recent review has shown that knowledge
translation and targeted implementation efforts may be
particularly effective in changing SCI/D provider behav-
ior and improving patient outcomes [38]. Our findings
align with these studies and corroborate the need to in-
crease provider awareness and knowledge around guide-
lines, ensure guidelines are tailored to the provider context,
and enhance leadership support and provider education
[16, 22, 39].
Provider perceptions and attitudes affect implementation
of precautions to prevent transmission of drug-resistant
pathogens such as MRSA, but a key lesson from this and
other studies is that improving perceptions and attitudes
alone may not be sufficient to fully implement best prac-
tices or guidelines for prevention [22, 40]. As evidenced in
our work, barriers to implementation included lack of
awareness of the guidelines and challenges in following
contact precautions and cohorting and isolating MRSA-
positive patients. Similarly, Seibert and colleagues found
that adhering to hand hygiene and contact precautions was
challenging for providers even though they felt that they
had knowledge and ability to do so [40]. These barriers
result in a lack of adherence to the guidelines in spite of
provider knowledge, perceptions and motivation to follow
them, and point to a disconnect between provider percep-
tions and prevention practices. This disconnect may explain
some of the dissonant results we noted across perceived
levels of implementation.
We identified perceived strengths and gaps in implemen-
tation that can be applied to future and ongoing initiatives.
First, successful implementation of the SCI/D MRSA pre-
vention guidelines requires strong leadership support and
strong perceived strength of evidence among providers.
The importance of leadership support to implement
guidelines has been documented previously [22], and
recent findings also demonstrate the importance of
providers’ perceived evidence of infection prevention
practices for successful implementation [41]. These are
key strengths we found in our evaluation of the early
implementation efforts that can be incorporated into
future implementation strategies. In addition, we found
that the presence of local MPCs, whose role centers on
overseeing compliance with the guidelines, was often
helpful for implementation; however, a strong group of
SCI/D providers could effectively support MRSA pre-
vention activities. This is particularly important in the
SCI/D setting given patient needs for interdisciplinary,
integrated, and team-based care [38]. Further, future
efforts should ensure that guideline dissemination reaches
the full range of providers that care for patients with SCI/D
and should focus on disseminating guidelines to pro-
viders with hands-on contact with patients in inpatient
and other SCI/D care settings. We found that nurses
were more likely to report full implementation of the
guidelines compared to other providers, perhaps due to
responsibilities and activities that require nurses to be
more aware of the recommended prevention practices.
Our findings also showed that guideline awareness was
strongest among providers in the initial years of their
work experience with SCI/D patients, suggesting a need
for enhanced reinforcement of the guidelines targeted
to more experienced providers. Next, education around
the guidelines should be provided frequently to all SCI/D
providers and should focus on SCI/D-specific recommen-
dations for MRSA prevention. In light of these data and
the SCI/D community’s need to obtain chronic care from a
variety of providers, strategies that focus on education and
training for all SCI/D providers are needed. This is sup-
ported by a recent study indicating a need for increased
education efforts for SCI/D providers to prevent MRSA
[27]. Finally, our survey findings revealed perceived barriers
to performing key practices included in the SCI/D MRSA
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prevention guidelines, such as cohorting and isolating
MRSA-positive patients, following contact precautions and
gowning and gloving in-between patient encounters. Per-
ceived barriers to changing gowns and gloves in-between
patients varied by perceived level of implementation, in-
cluding unique factors to SCI/D, such as unit layout and
multi-bed rooms, and should be addressed to enhance on-
going implementation of infection prevention activities.
PARiHS was used to evaluate factors influencing guide-
line implementation in SCI/D Centers and to identify im-
plementation strategies that can be used for current and
planned efforts. The PARiHS framework was beneficial in
systematically building knowledge of the context around
guideline implementation in SCI/D Centers, given that data
in this area remains limited. Our results illustrate the ways
in which implementation in the SCI/D setting is shaped by
a combination of contextual, evidence, and facilitation ele-
ments and sub-elements; this aligns with recent literature
demonstrating that implementation is a facilitated process
that rests upon interactions between individuals, evidence,
and context [25]. This framework may be useful to struc-
ture evaluations of other implementation efforts in SCI/D
beyond infection prevention. Further theory-guided and
mixed method studies are needed that examine the adop-
tion of prevention guidelines for other HAIs in SCI/D to
build a knowledge base around the impact of SCI/D-spe-
cific characteristics on implementation of infection preven-
tion guidelines.
Several study limitations should be noted. Our survey
response rate was lower than expected, where physicians
had the lowest response rate. Lower physician response
rates have also been noted in prior survey studies
examining perceptions of clinical guidelines [22, 42].
Additionally, qualitative interviews were conducted
with a relatively small group of providers. As a result,
our findings may not be applicable to other providers’
practices and their experiences at VA SCI/D Centers.
Finally, the cross-sectional nature of the research design,
reliance on self-reported data, and recruitment of provider
interviews through the SCI/D Chiefs might have pre-
sented study biases. However, the need to identify mem-
bers with direct experience related to MRSA efforts in the
SCI/D Centers was necessary and a means to developing a
purposive sample [27, 43].
Conclusions
Recent findings demonstrate that the VA MRSA Preven-
tion Initiative has been successful and that MRSA infec-
tion rates in VA SCI/D Centers have declined [7]. A key
step in developing and maintaining effective prevention
strategies is understanding factors that influenced early
implementation. Facilitators for implementing the SCI/D
MRSA prevention guidelines in the VA included enhanced
leadership support and provider education around the
guidelines, improved dissemination of the guidelines that
reached all SCI/D providers, and strong perceived evi-
dence supporting the guidelines. To successfully imple-
ment infection prevention guidelines in SCI/D settings,
providers and researchers should ensure that (1) guideline
dissemination reaches the full range of SCI/D providers,
including those working in inpatient, outpatient, and other
care settings (2) provider education is frequent and sys-
tematic, (3) leadership support is strong, and (4) barriers
unique to the recommendations are addressed. Findings
from this study contribute to the evidence base around
implementation of SCI/D MRSA prevention guidelines in
VA SCI/D Centers and can be used to enhance infection
prevention and implementation efforts in SCI/D beyond
MRSA as well as in other specialty care populations.
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